Evidence map›Paper›PMID 37399336›Full record

ArticleHuman brain mapping2023

Spatiotemporal profile of atrophy in the first year following moderate-severe traumatic brain injury.

Daniel J Brennan, Jeffrey Duda, Jeffrey B Ware, John Whyte, Joon Yul Choi, James Gugger, Kristen Focht, Alexa E Walter, Tamara Bushnik, James C Gee and 2 more

Open access · goldAbstract read
In one paragraph

Article in Human brain mapping, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed, 1 pooled it
1.7field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 1 synthesis or guideline pooled it, 8 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 7 institutions in 2 countries.

Daniel J BrennanCUNY Neuroscience Collaborative, The Graduate Center, City University of New York, New York, New York, United States.ORCID 0000-0002-3880-3146
Jeffrey DudaDepartment of Radiology, University of Pennsylvania Perelman School of Medicine, Philadelphia, Pennsylvania, United States.ORCID 0000-0002-5031-5735
Jeffrey B WareDepartment of Radiology, University of Pennsylvania Perelman School of Medicine, Philadelphia, Pennsylvania, United States.
John WhyteMoss Rehabilitation Research Institute, Einstein Healthcare Network, Elkins Park, Pennsylvania, United States.
Joon Yul ChoiDepartment of Molecular, Cellular, and Biomedical Sciences, CUNY School of Medicine, The City College of New York, New York, New York, United States.ORCID 0000-0002-2428-0209
James GuggerDepartment of Neurology, University of Pennsylvania Perelman School of Medicine, Philadelphia, Pennsylvania, United States.
Kristen FochtWidener University School for Graduate Clinical Psychology, Chester, Pennsylvania, United States.
Alexa E WalterDepartment of Neurology, University of Pennsylvania Perelman School of Medicine, Philadelphia, Pennsylvania, United States.
Tamara BushnikNYU Grossman School of Medicine, New York, New York, United States.
James C GeeDepartment of Radiology, University of Pennsylvania Perelman School of Medicine, Philadelphia, Pennsylvania, United States.
Ramon Diaz-ArrastiaDepartment of Neurology, University of Pennsylvania Perelman School of Medicine, Philadelphia, Pennsylvania, United States.
Junghoon J KimCUNY Neuroscience Collaborative, The Graduate Center, City University of New York, New York, New York, United States.ORCID 0000-0001-5729-8993
University of Pennsylvania · USPenn Center for AIDS Research · USThe Graduate Center, CUNY · USCity College of New York · USEinstein Healthcare Network · USNew York University · USWidener University · US

Funding

Research Center in Minority Institutions (RCMI) at City CollegeU54MD017979 · NIMHD · CITY COLLEGE OF NEW YORK · PI M. Felice Marina GHILARDI · 2024 to 2026
$15.9M
Longitudinal MRI Investigation of Traumatic Microvascular InjuryR01NS125408 · NINDS · UNIVERSITY OF PENNSYLVANIA · PI Jeffrey B Ware · 2022 to 2026
$3.9M
A Longitudinal Multi-modal Neuroimaging Investigation of Functional Recovery afteR01NS065980 · NINDS · CITY COLLEGE OF NEW YORK · PI KIM, JUNGHOON JOHN · 2011 to 2015
$1.4M
NIMHD NIH HHS U54 MD017979NINDS NIH HHS R01 NS065980NINDS NIH HHS R01 NS125408
6 · The paper itself

Abstract

Traumatic brain injury (TBI) triggers progressive neurodegeneration resulting in brain atrophy that continues months-to-years following injury. However, a comprehensive characterization of the spatial and temporal evolution of TBI-related brain atrophy remains incomplete. Utilizing a sensitive and unbiased morphometry analysis pipeline optimized for detecting longitudinal changes, we analyzed a sample consisting of 37 individuals with moderate-severe TBI who had primarily high-velocity and high-impact injury mechanisms. They were scanned up to three times during the first year after injury (3 months, 6 months, and 12 months post-injury) and compared with 33 demographically matched controls who were scanned once. Individuals with TBI already showed cortical thinning in frontal and temporal regions and reduced volume in the bilateral thalami at 3 months post-injury. Longitudinally, only a subset of cortical regions in the parietal and occipital lobes showed continued atrophy from 3 to 12 months post-injury. Additionally, cortical white matter volume and nearly all deep gray matter structures exhibited progressive atrophy over this period. Finally, we found that disproportionate atrophy of cortex along sulci relative to gyri, an emerging morphometric marker of chronic TBI, was present as early as 3 month post-injury. In parallel, neurocognitive functioning largely recovered during this period despite this pervasive atrophy. Our findings demonstrate msTBI results in characteristic progressive neurodegeneration patterns that are divergent across regions and scale with the severity of injury. Future clinical research using atrophy during the first year of TBI as a biomarker of neurodegeneration should consider the spatiotemporal profile of atrophy described in this study.

Indexed as

Brain InjuriesBrain Injuries, TraumaticBrain Injury, ChronicWhite MatterAtrophyBrainHumansatrophylongitudinalneurodegenerationtraumatic axonal injurytraumatic brain injury

Identifiers

PMID37399336
PMCPMC10400790
OpenAlexW4382931111

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.